Skip to main content
. 2012 Apr 24;12:37. doi: 10.1186/1471-230X-12-37

Figure 2.

Figure 2

A total of 44 subjects were enrolled. One subject did not continue treatment because of massive bleeding during ESD. The remaining 43 subjects underwent subsequent endoscopic treatments according to the study protocol. Twenty-one subjects were randomly assigned to the duodenal balloon group and 22 to the placebo (regular) group.